Exclusive: Anthropic in Talks With Samsung to Manufacture Custom AI Chip Save 25% to unlock this story

Sign in
Subscribe

    Data Tools

    • About Pro
    • The Executives Leading the Data Center Race
    • The Next GPs 2026
    • The Next GPs 2025
    • The Rising Stars of AI Research
    • Leaders of the AI Shopping Revolution
    • Enterprise Software Startup Takeover List
    • Org Charts
    • The Information 50 2025
    • Generative AI Takeover List
    • Generative AI Database
    • AI Chip Database
    • AI Data Center Database
    • Tech IPO Tracker
    • Tech Sentiment Tracker
    • Gigafactory Database

    Special Projects

    • The Information 50 Database
    • VC Diversity Index
    • Enterprise Tech Powerlist
  • Org Charts
  • Deep Research
  • Tech
  • Finance
  • Weekend
  • Charts
  • Events
  • TITV
    • Directory

      Search, find and engage with others who are serious about tech and business.

    • Forum

      Follow and be a part of discussions about tech, finance and media.

    • Brand Partnerships

      Premium advertising opportunities for brands

    • Group Subscriptions

      Team access to our exclusive tech news

    • Newsletters

      Journalists who break and shape the news, in your inbox

    • Video

      Catch up on conversations with global leaders in tech, media and finance

    • Partner Content

      Explore our recent partner collaborations

      XFacebookLinkedInThreadsInstagram
    • Help & Support
    • RSS Feed
    • Careers
    Sign in
  • About Pro
  • The Executives Leading the Data Center Race
  • The Next GPs 2026
  • The Next GPs 2025
  • The Rising Stars of AI Research
  • Leaders of the AI Shopping Revolution
  • Enterprise Software Startup Takeover List
  • Org Charts
  • The Information 50 2025
  • Generative AI Takeover List
  • Generative AI Database
  • AI Chip Database
  • AI Data Center Database
  • Tech IPO Tracker
  • Tech Sentiment Tracker
  • Gigafactory Database

SPECIAL PROJECTS

  • The Information 50 Database
  • VC Diversity Index
  • Enterprise Tech Powerlist
Deep Research
TITV
Tech
Finance
Weekend
Charts
Events
Newsletters
  • Directory

    Search, find and engage with others who are serious about tech and business.

  • Forum

    Follow and be a part of discussions about tech, finance and media.

  • Brand Partnerships

    Premium advertising opportunities for brands

  • Group Subscriptions

    Team access to our exclusive tech news

  • Newsletters

    Journalists who break and shape the news, in your inbox

  • Video

    Catch up on conversations with global leaders in tech, media and finance

  • Partner Content

    Explore our recent partner collaborations

Subscribe
  • Sign in
  • Search
  • Opinion
  • Venture Capital
  • Artificial Intelligence
  • Startups
  • Market Research
    XFacebookLinkedInThreadsInstagram
  • Help & Support
  • RSS Feed
  • Careers

In-depth insights in seconds. Ask Deep Research.

Scientists Accuse FDA of Bad Science on BPA

The FDA's headquarters in Maryland. Photo by AP
By
Reed Albergotti
[email protected]Profile and archive

The Food and Drug Administration has long been at war with academic scientists about whether a compound used in water bottles and thousands of other products called bisphenol A is safe. For a decade, the agency has dismissed hundreds of academic studies showing potential harm caused by BPA, as it is known, instead citing studies sponsored by the plastics industry.

But for the past six years, the two sides have tried to reach consensus by jointly working on a massive series of animal studies investigating BPA’s safety. Recently, it became clear that the efforts at a reconciliation had broken down. Several of the scientists went public this week, including in interviews with The Information, saying that the studies clearly show the dangers posed by BPA.

Laura Vandenberg, an associate professor who studies BPA at the University of Massachusetts Amherst, said the FDA’s own data shows that BPA has a wide range of effects at low doses, including an increase in mammary cancer, inflammation of the prostate, kidney damage and obesity.

Recommended